Intuitive Machines is upgraded to Strong Buy with a $21/share target, driven by the Lanteris Space Systems acquisition and potential for Golden Dome program funding. LUNR's acquisition of Lanteris and ...

There’s a lot of debate about weight machines in the fitness world. Some people gravitate towards them because they seem a heck of a lot easier than cranking out some reps with a pair of dumbbells or ...

New details emerge in the Derek Rosa case, where the 15-year-old is accused of murdering his mother. Law&Crime's Angenette Levy covers the latest developments. Kennedy Center Christmas Eve jazz ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Seth Berkman Seth Berkman is a fitness writer. He incorporates testing into ...

Valve’s second big foray into first-party PC hardware isn’t a sequel to the much-imitated Steam Deck portable, but rather a desktop computer called the Steam Machine. And while it could go on your ...

Just how powerful will the Steam Machine be? Based on expert analysis of the specs revealed by Valve when it announced the Steam Machine on Wednesday, its new compact, console-like gaming PC is aimed ...

It's not a "GameCube" per se, but Valve's Steam Machine will bring your Steam library to your living room. Reading time 4 minutes Valve is entering the console race, and it’s doing so in the most ...

The Steam Machine marks Valve’s long-awaited return to the console wars. It looks slick and sounds powerful enough to play modern games on decent settings. But Valve is leaving the biggest question of ...

Intuitive Machines announced last week an $800 million acquisition that will catapult the one-time startup into the space industry establishment. The company’s planned purchase of Lanteris Space ...

Deal includes $450 million cash, $350 million in Intuitive Machines stock Company aims to expand beyond lunar projects Lanteris builds satellites for defense, communications Nov 4 (Reuters) - Lunar ...

The global slitting machine market is on a trajectory of steady growth, projected to reach USD 541.4 million in 2025 and achieve USD 780.8 million by 2035, registering a compound annual growth rate ...

Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded FDA approval.